Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2163-2165

  Hasenburg, A ^c   Tong, X W ^c   Rojas Martinez, A ^a   Nyberg Hoffman, C ^a   Kieback, C C ^c   Kaplan, A L ^c   Kaufman, R H ^c   Ramzy, I ^a   Aguilar Cordova, E ^a   Kieback, Dirk G ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

Acyclovir; Gene therapy; Intraperitoneal therapy; Ovarian cancer; Valacyclovir

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; THYMIDINE KINASE; TOPOTECAN; VALACICLOVIR;

ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; SOLID TUMOR; SUICIDE GENE;

ACYCLOVIR; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; FEMALE; GENE THERAPY; HUMANS; INSTILLATION, DRUG; OUTPATIENTS; OVARIAN NEOPLASMS; PRODRUGS; SIMPLEXVIRUS; THYMIDINE KINASE; VALINE;

EID: 0032800784     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tong X-W, Block A, Chen S-H et al: In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Gyn Onc 61: 175-179, 1996.
2. Morris JC, Blaese RM, Wildner O: The addition of Topotecan (TPT) enhances the antitumor effect of herpes simplex virus-1 thymidine kinase (HSV-TK) ganciclovir (GCV) cancer gene therapy in vivo, Abstract American Society of Clinical Oncology. Los Angeles, CA, 1998.
3. O'Malley BWJ, Chen SH, Schwartz MR, et al: Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080-1085, 1995.
4. Perez-Cruet MJ, Trask TW, Chen S-H et al: Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 39: 506-511, 1994.
5. Yee D, McGuire SE, Brunner N et al: Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Human Gene Therapy 7: 1251-1257, 1996.
6. Timme TL, Hall SJ, Barrios R et al: Local toxicity and vector spread after direct intraprostatic injection of recombinant adenovirus containing the herpes simplex thymidine kinase gene followed by ganciclovir therapy in mice. Personal communication, 1998.
7. Moolten FL, Wells JM: Curability of tumors bearing herpes simplex virus thymidine kinase gene. J Natl Cancer Inst 82: 297-300, 1990.
8. Ram Z, Culver KW, Walbridge S et al: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993.
9. Cheng YC, Grill SP, Dutschman GE et al: Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes simplex virus compound, in herpes simplex virus-infected cells. J Biol Chem: 12460-12464, 1983.
10. Tong X-W, Engehausen DG, Kaufman RH et al: Improvment of gene therapy for ovarian cancer by using acyclovir: In vitro study of adenovirus mediated thymidine kinase gene therapy followed by exposure to acyclovir vs conventional ganciclovir. Anticancer Res 18: 713-718, 1998.
11. Drucker JL, King DH: Management of viral infections in AIDS patients. Infection 15: 32-22, 1987.
12. DeArmond B: Safety considerations in the use of ganciclovir in immunocompromised patients. Transplant Proc 23: 26-29, 1991.
13. Reed EC, Dandliker PS, J.D. M: Treatment of cytomegalivirus pneumonia with 9-(2-hydroxy-1-(hydroxymethyl) ethoxymethyl) guanine and high-dose corticosteroids. Ann Intern Med 105: 214-215, 1986.
14. Roche Laboratories 1, Nuttley, NJ: Ganciclovir. Prod Info Cytovene®, 1998.
15. Weller S, Blum MR, Doucette M et al: Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54: 595-605, 1993.
16. Wellcome G: Valtrex (valacyclovir hydrochloride) Caplets. Research Triangle Park, 1997.
17. Kieback DG, Shine DH, Agoulnik I et al: Adenovirus mediated tymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to selected chemotherapeutic agents. Anticancer Res 18: 3421-3426, 1998.